Prescription sequence symmetry analysis: Assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 8, 2015, Pages 858-864

  Pratt, Nicole ^a   Chan, Esther W ^b   Choi, Nam Kyong ^c   Kimura, Michio ^d   Kimura, Tomomi ^d   Kubota, Kiyoshi ^e   Lai, Edward Chia Cheng ^f   Man, Kenneth K C ^b   Ooba, Nobuhiro ^e   Park, Byung Joo ^g,h   Sato, Tsugumichi ^e   Shin, Ju Young ^h   Wong, Ian C K ^b   Kao Yang, Yea Huei ^f   Roughead, Elizabeth E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Seoul National University Hospital   (South Korea)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g Seoul National University College of Medicine   (South Korea)

^h Korea Institute of Drug Safety and Risk Management   (South Korea)

Author keywords

Amiodarone; Hyperthyroidism; Pharmacoepidemiology; Pharmacovigilance; Prescription symmetry analysis

Indexed keywords

ALLOPURINOL; AMIODARONE; THYROXINE;

ADVERSE DRUG REACTION; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DRUG DISPENSING; DRUG INFORMATION; GOUT; HONG KONG; HUMAN; HYPOTHYROIDISM; JAPAN; KOREA; PHARMACEUTICS; PRESCRIPTION; PRESCRIPTION SEQUENCE SYMMETRY ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL DETECTION; TAIWAN; ANALYSIS OF VARIANCE; ASIA; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FACTUAL DATABASE; MULTICENTER STUDY; ODDS RATIO; PHARMACOEPIDEMIOLOGY; REPRODUCIBILITY; RISK FACTOR; STANDARDS; TIME FACTOR; TRENDS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AMIODARONE; ANALYSIS OF VARIANCE; ASIA; AUSTRALIA; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GOUT; HUMANS; HYPOTHYROIDISM; ODDS RATIO; PHARMACOEPIDEMIOLOGY; PHARMACOVIGILANCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; THYROXINE; TIME FACTORS;

EID: 84939001135     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3780     Document Type: Article

References (15)

1. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7(5): 478-484.
2. Wahab IA, Pratt NL, Wiese MD, et al. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiol Drug Saf 2013; 22(5): 496-502.
3. Pratt N, Andersen M, Bergman U, et al. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf 2013; 22(9):915-924. doi: 10.1002/pds.3440.
4. Lucas RM, McMichael AJ. Association or causation: evaluating links between "environment and disease". Bull World Health Organ 2005; 83(10): 792-795.
5. AsPEN collaborators, Andersen M, Bergman U, et al. The Asian Pharmacoepidemiology network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf 2013; 22(7): 700-704.
6. Cohen-Lehman J, Dahl P, Danzi S, Klein I. Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol 2010; 6(1): 34-41.
7. Bogazzi F, Tomisti L, Bartalena L, et al. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 2012; 35(3): 340-348.
8. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991; 91(5): 507-511.
9. Batcher EL, Tang XC, Singh BN, et al. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. Am J Med 2007; 120(10): 880-885.
10. Rouleau F, Baudusseau O, Dupuis JM, et al. Incidence and timing of thyroid dysfunction with long-term amiodarone therapy. Arch Mal Coeur Vaiss 2001; 94(1): 39-43.
11. Bouvy ML, Heerdink ER, Hoes AW, et al. Amiodarone-induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiol Drug Saf 2002; 11(7): 601-606.
12. Vorperian VR, et al. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997; 30(3): 791-798.
13. Kuhn M, Campillos M, Letunic I, et al. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 2010; 6: 343.
14. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009; 18(6): 483-491.
15. Higgins JPT, Green SE (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.